News of the WeekDRUG SAFETY

Withdrawal of Vioxx Casts a Shadow Over COX-2 Inhibitors

See allHide authors and affiliations

Science  15 Oct 2004:
Vol. 306, Issue 5695, pp. 384-385
DOI: 10.1126/science.306.5695.384

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Will other COX-2 inhibitors suffer a fate similar to that of Vioxx, which was recently found to increase the risk of heart attacks and stroke?